Lutris Pharma: Funding, Investors & Team (Sep 2026)
Lutris Pharma creates medications that enhance the efficiency of anti-cancer treatments. One of their products, LUT014, is a topical B-Raf inhibitor that helps patients receive EGFR inhibitors without experiencing common skin-related side effects. Founded in 2015, Lutris Pharma is located in Tel Aviv-yafo, Israel.
Lutris Pharma has raised $30.0M across 1 funding round on record, the most recent an undisclosed round of $30.0M announced in Jan 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Lutris Pharma Company Profile and Key Stats
Latest funding round on record: Jan 2025.
Lutris Pharma Funding Rounds
Lutris Pharma Founders and Leadership Team
No contact details are on record for this team yet.
Lutris Pharma Funding Compared to Other Biotechnology Startups
Lutris Pharma's latest round of $30.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Lutris Pharma in Biotechnology and Tel Aviv-yafo
Companies Similar to Lutris Pharma
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
Lutris Pharma Funding FAQs
What does Lutris Pharma do?
Lutris Pharma creates medications that enhance the efficiency of anti-cancer treatments. One of their products, LUT014, is a topical B-Raf inhibitor that helps patients receive EGFR inhibitors without experiencing common skin-related side effects. Founded in 2015, Lutris Pharma is located in Tel Aviv-yafo, Israel.
How much funding has Lutris Pharma raised?
Lutris Pharma has raised $30.0M across 1 round on record. The most recent is an undisclosed round of $30.0M announced in Jan 2025.
When did Lutris Pharma last raise funding?
Lutris Pharma's most recent funding round on record is an undisclosed round of $30.0M, announced in Jan 2025.
Who founded Lutris Pharma?
FundedIQ lists Noa Shelach (Founder) at Lutris Pharma.
Where is Lutris Pharma headquartered?
Lutris Pharma is based in Tel Aviv-yafo, Tel Aviv, Israel.
How many employees does Lutris Pharma have?
Lutris Pharma is in the 1-10 employee band.
How does Lutris Pharma's funding compare to other Biotechnology startups?
Lutris Pharma's latest round of $30.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Lutris Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Lutris Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.